Eris Lifesciences Ltd.
ERIS Share PricePharmaceuticals & Drugs
₹1,559.9
-1.3 (-0.1%)
As on December 4, 2025
Exchange Scrips: BSE540596NSEERISISININE406M01024
Market Cap ₹ 21,182 Cr
P/E Ratio 60.38
Dividend Yield 0.47 %
Performance
Market performance
Open1,566
High1,569.3
Volumes77,218
Prev1,559.9
Low1,545.1
As on2025-12-04
Historical performance
1 Year High1,910
3 Year High1,910
5 Year High1,910
1 Year Low1,097.2
3 Year Low551.3
5 Year Low473.5
Fundamentals
Company Valuation
Market Cap (₹Cr)
21,182
Face Value (₹)
1
P/E Ratio
60.38
Dividend Yield
0.47 %
Investment Returns
1 Year
6%
3 Years
134.6%
5 Years
194.2%
10 Years
N/A
Technicals
| Indicators | Value | Signal |
|---|---|---|
| 5-DMA | 1,573.54 | Bearish |
| 10-DMA | 1,609.87 | Bearish |
| 20-DMA | 1,597.39 | Bearish |
| 50-DMA | 1,600.33 | Bearish |
| 100-DMA | 1,671.13 | Bearish |
| 200-DMA | 1,569.53 | Bearish |
Shareholding Pattern
| Field | Sep-2025 | Jun-2025 | Mar-2025 | Dec-2024 | Sep-2024 |
|---|---|---|---|---|---|
| Promoters | 5 | 5 | 5 | 5 | 5 |
| Foreign Investors | --- | --- | --- | --- | --- |
| Domestic Investors | 5 | 5 | 5 | 5 | 5 |
| Public Investors | 59433 | 52220 | 50082 | 53309 | 46341 |
| Government | 1 | 1 | 1 | 1 | --- |
Financials
Below figures are in Rs. Crores
Balance Sheet
Below figures are in Rs. Crores
Cash Flow
Below figures are in Rs. Crores
0%
Negative
Neutral
Positive
- The stock has a PE ratio of 60.38.
- 3Y Stock Price CAGR of the stock is 33.2.
- The stock has a beta of 0.4.
- In the last financial year, the company had an EBITDA of ₹10356 Million.
- The company generated revenue of ₹28936 Million in the previous financial year.
Eris Lifesciences Ltd.
1559.9-1.3 (-0.1%)
₹
Investment Amount: ₹ 1000000
Current Value: ₹ 1075793.1
No. of Shares: 690 (Approx)
Performance:7.6%
P/L: ₹75793.1
Top Gainers
Peer Comparison
Get Your Portfolio Reviewed
